Angiotensin II type 1 receptor polymorphisms and susceptibility to hypertension: a HuGE review.
meta_analysis · Level I
Where this comes from
- Record sourced from PubMed, PMID 18641512.
- Also identified by DOI 10.1097/gim.0b013e3181809613 and PMC identifier 4993203.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
The angiotensin II type 1 receptor (AGTR1) plays an integral role in blood pressure control, and is implicated in the pathogenesis of hypertension. Polymorphisms within this gene have been extensively studied in association with hypertension; however, findings are conflicting. To clarify these data, we conducted a systematic review of association studies of AGTR1 polymorphisms and hypertension, and performed a meta-analysis of the rs5186 variant. Results show that the currently available literature is too heterogeneous to draw meaningful conclusions. The definition of hypertension and gender composition of individual studies helps to explain this heterogeneity. Although the structure and splicing pattern of AGTR1 would suggest a likely effect of polymorphisms within the promoter region on gene function, few studies have been conducted thus far. In conclusion, there is insufficient evidence that polymorphisms in the AGTR1 gene are risk factors for hypertension. However, most studies are inadequately powered, and larger well-designed studies of haplotypes are warranted.
Medical subject headings
- Disease Susceptibility
- Genetic Predisposition to Disease
- Hypertension
- Polymorphism, Genetic
- Receptor, Angiotensin, Type 1